Pilot experience with clopidogrel in the treatment of an .ST-elevation acute myocardial infarction

• Main Authors: S V Shalaev, N M Vorobyeva, A Kh Serescheva, E S Petrik, S A Akinina
• Format: Article
• Language: Russian
• Published: "Consilium Medicum" Publishing house 2004-06-01
• Series: Терапевтический архив
• Subjects: acute myocardial infarction; thrombolytic therapy; clopidogrel; aspirin; streptokinase; actilise
• Online Access: https://ter-arkhiv.ru/0040-3660/article/view/29841

Aim. To examine efficacy of clopidogrel before thrombolytic therapy (TLT) in patients with acute myocardial infarction (AMI). Material and methods. A total of 72 patients (48 males and 24 females) admitted to hospital within 6 hours since the onset of acute myocardial infarction (AMI) were divided into three groups. Group 1 and 2 patients (n = 38 and 20, respectively) were given a prehospital stress dose of aspirin (250- 500 mg), group 3 patients (n = 14) received this dose at admission. TLT with streptokinase or actilise (1500000 IU and 100 mg, respectively) was given to all the patients. Before TLT group 2 received a stress dose of clopidogrel (300 mg), after TLT - 75 mg/day. 12-Lead ECG, CFK activity and troponine content examinations were made. The patients were observed for 30 days. The recovery of coronary circulation (CC) was evaluated by dynamics of a total lowering of the elevated ST segment. Results. CC completely recovered 60 min after TLT in 16, 10 and 7% patients of groups 1, 2 and 3, respectively. CC recovered partially in 24, 55 and 7% patients, respectively. In 90 min after TLT partial recovery of CC was observed in 21, 31 and 43%, respectively; in 180 min the effect was absent in 19, 15 and 38%, respectively. 30-Day lethality was 11.1% and was high in group 3. No lethal outcomes were seen in group 2. Conclusion. It is possible to achieve better myocardial reperfusion after TLT and improve 30-day outcomes in MI patients given combined antithrombocytic therapy.